NCT03761069 2022-02-02Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute LeukemiasPTC TherapeuticsPhase 1 Terminated33 enrolled
NCT00508586 2016-03-03PTC299 and Hormonal Agent for Treatment of Metastatic Breast CancerPTC TherapeuticsPhase 1 Completed33 enrolled
NCT01158300 2015-05-04PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System TumorsPediatric Brain Tumor ConsortiumPhase 1 Completed28 enrolled